These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16864765)
21. Quality of life of elderly people on warfarin for atrial fibrillation. Das AK; Ahmed A; Corrado OJ; West RM Age Ageing; 2009 Nov; 38(6):751-4. PubMed ID: 19710070 [No Abstract] [Full Text] [Related]
23. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation. Turi ZG Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149 [No Abstract] [Full Text] [Related]
24. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823 [TBL] [Abstract][Full Text] [Related]
25. Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment. Lane D; Lip GY Age Ageing; 2005 Jan; 34(1):1-3. PubMed ID: 15591476 [No Abstract] [Full Text] [Related]
26. Identifying AF patients at risk of stroke: can prothrombotic indices improve things? Watson T; Lip GY Int J Cardiol; 2008 Jun; 126(3):299-301. PubMed ID: 18077017 [No Abstract] [Full Text] [Related]
27. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation. Leey JA; McCabe S; Koch JA; Miles TP Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951 [TBL] [Abstract][Full Text] [Related]
28. Sustainability and impact of warfarin compliance for atrial fibrillation. Kuo S; Burrill J Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828 [No Abstract] [Full Text] [Related]
29. Does long-term warfarin affect the quality of life of older people? Das AK; Willcoxson P; Corrado OJ Age Ageing; 2005 May; 34(3):312-3. PubMed ID: 15863424 [No Abstract] [Full Text] [Related]
30. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
31. The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe? Karthikeyan G; Eikelboom JW Thromb Haemost; 2010 Jul; 104(1):45-8. PubMed ID: 20458437 [No Abstract] [Full Text] [Related]
32. The need for new oral anticoagulants in clinical practice. Hylek EM J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764 [TBL] [Abstract][Full Text] [Related]
33. Anticoagulation in elderly persons: a call for wider use. Portnoi VA Am Fam Physician; 1998 Jul; 58(1):39-40, 42. PubMed ID: 9672428 [No Abstract] [Full Text] [Related]
34. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation. Hammwöhner M; Goette A J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479 [TBL] [Abstract][Full Text] [Related]
35. Next generation anticoagulants may push warfarin to the wayside. Kirsch B Manag Care; 2011 Feb; 20(2):33-6. PubMed ID: 21428128 [No Abstract] [Full Text] [Related]